|
1
|
Amatya B, Khan F and Galea MP: Optimizing
post-acute care in breast cancer survivors: a rehabilitation
perspective. J Multidiscip Healthc. 10:347–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGurie WL: Breast cancer prognostic
factors: Evaluation guidelines. Natl Cancer Inst. 83:154–155. 1991.
View Article : Google Scholar
|
|
3
|
Abrahamsen JF, Bakken AM, Bruserud Ø and
Gjertsen BT: Flow cytometric measurement of apoptosis and necrosis
in cryopreserved PBPC concentrates from patients with malignant
diseases. Bone Marrow Transplant. 29:165–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zwick E, Bange J and Ullrich A: Receptor
tyrosine kinase as targets for anticancer drugs. Trends Mol Med.
8:17–23. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olaku O and White JD: Herbal therapy use
by cancer patients: A literature review on case reports. Eur J
Cancer. 47:508–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiménez-Orozco FA, López-González JS,
Nieto-Rodriguez A, Velasco-Velázquez MA, Molina-Guarneros JA,
Mendoza-Patiño N, García-Mondragón MJ, Elizalde-Galvan P,
León-Cedeño F and Mandoki JJ: Decrease of cyclin D1 in the human
lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung
Cancer. 34:185–194. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Finn GJ, Creaven BS and Egan DA: Daphnetin
induced differentiation of human renal carcinoma cells and its
mediation by p38 mitogen-activated protein kinase. Biochem
Pharmacol. 67:1779–1788. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaneko T, Tahara S and Takabayashi F:
Inhibitory effect of natural coumarin compounds, esculetin and
esculin, on oxidative DNA damage and formation of aberrant crypt
foci and tumors induced by 1,2-dimethylhydrazine in rat colons.
Biol Pharm Bull. 30:2052–2057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cory S, Huang DCS and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brady HJ and Gil-Gomez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Myong NH: Tissue microarray analysis of
Fas and FasL expressions in human non-small cell lung carcinomas
with reference to the p53 and bcl-2 overexpression. J Korean Med
Sci. 20:770–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang JS, Hsu YL, Kuo PL, Chiang LC and
Lin CC: Upregulation of Fas/Fas ligand mediated apoptosis by
gossypol in an immortalized human alveolar lung cancer cell line.
Clin Exp Pharmacol Physiol. 31:716–722. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Venditto VJ and Simanek EE: Cancer
therapies utilizing the camptothecins: A review of the in vivo
literature. Mol Pharm. 7:307–349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Packham G and Cleveland JL: c-Myc and
apoptosis. Biochim Biophys Acta. 1242:11–28. 1995.PubMed/NCBI
|
|
15
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: Role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung
JH, Yun SM, Han I, Lee SG, Kim DK, Kang M, et al: Janus activated
kinase 2/signal transducer and activator of transcription 3 pathway
mediates icariside II-induced apoptosis in U266 multiple myeloma
cells. Eur J Pharmacol. 654:10–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thoennissen NH, Iwanski GB, Doan NB,
Okamoto R, Lin P, Abbassi S, Song JH, Yin D, Toh M, Xie WD, et al:
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT
pathway and potentiates antiproliferative effects of gemcitabine on
pancreatic cancer cells. Cancer Res. 69:5876–5884. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryan AE, Shanahan F, O'Connell J and
Houston AM: Fas ligand promotes tumor immune invasion of colon
cancer in vivo. Cell Cycle. 5:246–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korkolopoulou P, Saetta AA, Levidou G,
Gigelou F, Lazaris A, Thymara I, Scliri M, Bousboukea K,
Michalopoulos NV, Apostolikas N, et al: c-FLIP expression in
colorectal carcinomas: Association with Fas/FasL expression and
prognostic implications. Histopathology. 51:150–156. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimada H, Takeda A, Arima M, Okazumi S,
Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, et
al: Serum p53 antibody is a useful tumor marker in superficial
esophageal squamous cell carcinoma. Cancer. 89:1677–1683. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Law PT and Wong N: Emerging roles of
microRNA in the intracellular signaling networks of hepatocellular
carcinoma. J Gastroenterol Hepatol. 26:437–449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xi S, Kevin FD and Kimak M: Decreased
SIRT1, expression by promoter methylation in squamous cell
carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
